Cellebrite DI (NASDAQ:CLBT) Stock Rating Lowered by Wall Street Zen

Cellebrite DI (NASDAQ:CLBT – Get Free Report) was downgraded by research analysts at Wall Street Zen from a “buy” rating to a “hold” rating in a research report issued to clients and investors on Saturday. CLBT has been the subject of a number of other reports. Weiss Ratings reissued a “sell (d+)” rating on shares [...]